Press Release
The Seongbuk District Pharmaceutical Association in Seoul held an executive board meeting to discuss their business plans.
2024.09.09 15:39- 작성자 관리자
- 조회 193
[DailyPharm Reporter: Ji-Eun Kim] The Seongbuk District Pharmaceutical Association in Seoul, led by President Myung-Sook Choi, held its 8th executive board meeting on the 19th in the small conference room of the district association hall to discuss reports and key agenda items.
At the meeting, the Seongbuk District Pharmaceutical Association presented several reports, including the outcomes of a roundtable discussion with four healthcare professional organizations, details of the Health Seoul Festival, the overseas workshop for members, refresher training for non-compliant members, and the projects involving cleaning member pharmacies' signage and windows.
The agenda items discussed included preparations for the Seoul Pharmaceutical Association’s 2023 annual audit on November 14, and arrangements for a AGEs Society lecture on December 19.
Additionally, they discussed participation in the Women Pharmacist Leaders Conference on December 17 at The K-Hotel Seoul and encouraged members to join the Bukhansan Dulle-gil hiking event on November 5.
Source: [DailyPharm] (http://www.dailypharm.com)
At the meeting, the Seongbuk District Pharmaceutical Association presented several reports, including the outcomes of a roundtable discussion with four healthcare professional organizations, details of the Health Seoul Festival, the overseas workshop for members, refresher training for non-compliant members, and the projects involving cleaning member pharmacies' signage and windows.
The agenda items discussed included preparations for the Seoul Pharmaceutical Association’s 2023 annual audit on November 14, and arrangements for a AGEs Society lecture on December 19.
Additionally, they discussed participation in the Women Pharmacist Leaders Conference on December 17 at The K-Hotel Seoul and encouraged members to join the Bukhansan Dulle-gil hiking event on November 5.
Source: [DailyPharm] (http://www.dailypharm.com)